Topic: Compounding Pharmacy

4 chapters across the catalog

Brigham Bueller recounts his testimony before the U.S. Senate regarding the suppression of compounding pharmacies by Big Pharma and insurance companies. He argues that insurance providers often block comprehensive blood work and non-addictive pain treatments to force patients toward more profitable, addictive options. Bueller advocates for a "cash pay" model to bypass insurance restrictions and allow for proactive, predictive healthcare.

Bill Gates reportedly donated $50 million to a dark money group supporting Kamala Harris, his first major political contribution in 20 years. This donation coincides with his indictment in the Netherlands over COVID-19 vaccine claims. The discussion also touches on the history of Big Pharma suing compounding pharmacies in the 1980s to prevent the production of affordable HIV treatments, prioritizing high profit margins over global health access.

Big Pharma provides 50% of the FDA's funding, leading to regulatory decisions that favor major manufacturers over compounding pharmacies. Eli Lilly and Novo Nordisk are currently lobbying the FDA to ban the compounding of GLP-1 weight loss drugs despite ongoing national shortages. This mirrors a 1980s tactic where pharmaceutical companies sued generic manufacturers to prevent affordable HIV treatments from reaching patients in Africa.